Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

hemantane

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Activities of noncompetitive NMDA receptor antagonists (aminoadamantane derivatives) were assessed in random-bred rats with… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
2017
2017
Activity of hemantane, an amino adamantane derivative, exhibiting the properties of lowaffinity non-competitive NMDA receptor… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2016
2016
The efficacy of some aminoadamantane derivatives used as neurodegeneration treatments is due to their ability to block NMDA… Expand
  • figure 1
  • figure 2
  • table 1
  • table 3
  • table 4
Is this relevant?
2015
2015
Hemantane demonstrated a pronounced antiparkinsonian activity in the model of hemiparkinsonian syndrome provoked in rats by… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
2014
2014
Hemantane is a novel antiparkinsonian drug that is undergoing clinical trials. Hemantane in the dosage range 10 – 40 mg/kg… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2013
2013
A large body of literature supports the idea that inflammation exacerbates neurodegenerative pathology. This idea is also… Expand
  • table 2
  • table 1
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2011
2011
Chronic administration of levodopa and benserazide (10 and 15 mg/kg, respectively) cause the development of dyskinesia in rats… Expand
Is this relevant?
2011
2011
The effects of anti-parkinsonian drug hemantane [(2-adamantyl)hexamethylenimine] (10 mg/kg, p. o.) and/or antibiotic drug… Expand
Is this relevant?
2008
2008
The effect of the antiparkinsonian drug hemantane on various subtypes of dopamine receptors in the striatum of Wistar rats have… Expand
Is this relevant?
2007
2007
The effect of Hemantane, a new 2-aminoadamantane derivative (N-adamant-2-ylhexamethylenimine hydrochloride) with antiparkinsonian… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?